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Abstract
Maternal body weight, measured as Body Mass Index (BMI) and infection during
pregnancy are established risk factors of multiple adverse birth outcomes that are also
associated with intellectual disability (ID) in children, but little is known of the
interaction of these two factors. This retrospective cohort study sought to explore whether
BMI is an effect modifier in the association between maternal infection during pregnancy
and ID of the child, and to make comparisons between categories of gestational infection.
The study sample (n= 124,047 after exclusion) was derived from Medicaid administrative
data. After preliminary analysis of interaction, stratified logistic regression analysis was
performed to assess magnitude of the effect modification by BMI. After adjusting for
confounders, there was evidence that BMI modified the relationship between infection
and ID. Underweight and obese mothers who experienced both a general infection (GI)
and a sexually transmitted infection (STI) during pregnancy had the highest odds of
having a child with ID, when compared to mothers of the same weight category with no
infection (ORs 2.76; 95% CI 1.68 – 4.53 & 1.47; 95% CI 1.13 – 1.91). Underweight
mothers who experienced both GI & STI during pregnancy also had higher odds of
having a child with ID compared to underweight mothers who had either STI or GI only
(ORs 2.41; 95% CI 1.44 - 4.03 & 3.76; 95% CI 1.54 - 9.17). There were no differences
between STI and GI categories across the BMI strata. These findings aligned with
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existing related literature, and contribute to understanding the complexities of the
relationships between infection, maternal BMI, and ID.
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Chapter 1
Introduction
1.1 Background & Significance
1.1.1 Intellectual Disability
Intellectual disability (ID) is a lifelong condition that affects approximately 1.14%
of children in the U.S, and often has a significant impact on the families (1). The American
Association of Intellectual and Developmental Disabilities (AAIDD) defines intellectual
disability as “disability characterized by significant limitations in both intellectual
functioning and in adaptive behavior, which covers many everyday social and practical
skills”(2). Diagnosis of ID is often complicated due to factors such as varied signs and
symptoms, unpredictable timelines, and stigma. Typically, diagnosis occurs during infancy
to early childhood, depending on reports of slow development from parents, and
confirmation assessment from a psychologist or physician. Due to the stigma of ID in
children, many parents are skeptical to report such problems, which leads to a delay in
diagnosis(3). The etiology of ID is still largely unknown; 50-60% of cases are attributed to
genetic or chromosomal factors which are rarely preventable outside of family planning
strategies(4). However, research has suggested that many cases are due to factors that are
modifiable, therefore making some cases preventable(4). Research on the prevention of ID
could provide at-risk individuals with essential tools that can be utilized through preconceptual counseling and other family planning strategies.
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1.1.2. Infection
Infection during pregnancy is a known cause of ID through multiple mechanisms.
Inflammation is a common immune-response and is often measured using C-reactive
protein in an individual (5). During pregnancy, inflammation has shown to increase the
risk of multiple adverse birth outcomes including preterm birth, low birthweight (LBW),
neonatal brain injury, and adverse neurobehavioral effects, through the mechanisms of
hypoxia or ischemia, which increase the probability of low IQ (5, 6). LBW, often a result
of gestational inflammation, is a predictor of adverse birth outcomes such as Cerebral Palsy
(CP) and ID. However, multiple studies have shown that even in cases of normal
birthweight, gestational infection significantly increases the risk of adverse health
outcomes such as CP, which is often closely linked with ID(7). Grether et al. suggested
this association was due to mechanisms such as fever and inflammation of the
genitourinary system(7). Further evidence has supported this idea of immune-mediated
mechanisms contributing to ID etiology. A 2015 retrospective cohort study found a 37%
increase (OR = 1.37 95% CI 1.28 – 1.47) in odds of autism spectrum disorders (ASD) in
women with infection, with no difference in trimester in which the exposure is identified.
Furthermore, the infections with the strongest association with ID were found to be
bacterial, respiratory, and genitourinary infections(8). Infections such as syphilis,
toxoplasmosis, cytomegalovirus, trichomoniasis, and rubella during pregnancy increases
the risk of congenital infection, which is also associated with ID in children(9). There has
been substantial research of the associations between infection and adverse birth outcomes
that have also been linked to ID, but very little research has been done on the causal
pathway between infection and ID, and factors that modify this relationship.

2

1.1.3. Sexually Transmitted Infection
Sexually transmitted infection (STI) during pregnancy has been a longstanding
public health problem. According the Center for Disease Prevention and Control (CDC),
STIs such as chlamydia, gonorrhea, and syphilis have significantly increased in women in
the last decade(10). Various studies have shown an association between various gestational
STIs and ID in children(10-13). STIs could be associated with ID in children through
various mechanisms such as immune-mediated responses (inflammation, fever), pre-term
birth, or through congenital infection. However, little research has been done on the causal
pathway from STI, to ID in children with considerations to potential relationship modifiers.
1.1.4 Obesity
Obesity is also a pro-inflammatory condition that has been steadily increasing in
prevalence within the last decade. According to the CDC, a woman is considered obese
with a body mass index (BMI) of 30.0 or higher. As of 2015, an estimated 38% of females
in the United States are considered obese(14). Prior research has shown a relationship
between obesity and ID in children through increased risk for preterm birth and
inflammation(15-18). Additionally, there has been evidence of obesity being associated
with an increased risk and severity of infection, though evidence has been conflicting (1820).
Obesity is a chronic risk factor with multiple adverse health implications including
inflammation and an individual’s susceptibility to various infections while simultaneously
increasing inflammation(18). As compared to the chronic inflammation caused by obesity,
infections cause an acute immune response, which is typically shorter term, but more
severe. Therefore, because of the possible relationship between obesity and infection, it is
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possible that obesity might be an effect modifier in the association between maternal
infections and ID. This study will assess the possible interaction between obesity and
maternal infections among pregnant women. These aims could contribute to our
understanding of possible preventable factors of ID and have implications for future
prevention.
1.2 Aim & Hypotheses
Aim: To explore whether body mass index is an effect modifier in the association
between maternal infection during pregnancy and intellectual disability in the child.
H1: BMI will be an effect modifier in the association between maternal infection
and intellectual disability, and this will manifest itself most in the obese category.
H2: Stratifying by BMI, the odds of ID will be significantly different between
each infection category, with mothers that experience a sexually transmitted
infection during pregnancy having greater odds than mothers who experienced a
general infection during pregnancy, and mothers that experienced both a general
infection & sexually transmitted infection during pregnancy having greater odds
than mothers with either a STI or GI alone.
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Chapter 2
Literature Review
2.1 Infection & Pregnancy
When a woman is pregnant, their body undergoes a process that lowers the
immune system to prevent adverse outcomes such as fetal distress and rejection instigated
by immune response. Because of this “immunological shift”, pregnant women are often
more susceptible to infection during their gestation(21-23). This produces a paradox of
health effects to the fetus; although the lowered immune responses protect it from the
system itself, having an infection during pregnancy can increase the harm to the fetus.
Infections such as rubella, cytomegalovirus, and coxsackie are known teratogenic
infections, and often result in fetal rejection, stillbirth, or growth restriction(21). The
mechanisms by which infections instigate adverse birth effects are heavily researched;
inflammation and in-utero or congenital infection being the most prominent.
2.2 Infection & Intellectual Disability
Though there has been substantial research done on the association between
infection and adverse fetal effects such as preterm birth, there is little available literature
on the association between gestational infection and ID. The literature that does exist has
shown that gestational infections can increase the risk of intellectual disability in
children. A 2015 cohort study found that mothers with an infection during pregnancy had
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a 30% increase in risk of autism spectrum disorder, and had a greater chance of ASD
with ID, rather than without an ID(8). Specific infections such as streptococcus B,
cytomegalovirus, rubella, herpes simplex virus, syphilis, toxoplasmosis, and coxsackie
are known to be associated with ID(24, 25). The mechanisms of infection increasing the
risk of ID in children are similar to, and often mediated by, adverse fetal outcomes such
as low birthweight, hypoxia, and inflammation (26).
2.3 Sexually Transmitted Infection & Pregnancy
Many STIs instigate both vaginal and systemic immune responses, which
increases risk of adverse effects such as fetal distress, hypoxia, preterm birth, and low
birthweight (27). STIs are also associated with a higher risk of congenital infection due to
the potential to pass infection through the placenta and the birth canal. Because of this,
early diagnosis and treatment of STIs during pregnancy are of utmost importance to
preventing negative outcomes to the fetus(28).
2.4 Sexually Transmitted Infections & Intellectual Disability
Much like general infections, significant research has been performed on the
relationship between STI and adverse fetal outcomes. Little research has been done
linking gestational STI and ID in children, but what research has been performed has
shown evidence of an association. Therefore, there is evidence to believe that STIs would
also be associated with ID. A 2001 retrospective cohort study found the risk of child ID
in women with UTIs were 16% higher than in women without a UTI(13). Additionally,
regardless of trimester, the odds of having a child with id in women diagnosed with
trichomoniasis were 1.28 (95% CI 1.12 – 1.46) times the odds of having a child with ID
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in women without trichomoniasis, and the odds of having a child with ID in women with
trichomoniasis during their second trimester were approximately 3 times the odds of
having a child with ID in women without trichomoniasis (11). Although these studies
assess trichomoniasis, there has been scant research done assessing STIs as a whole, and
research comparing the risk of ID in mothers with STIs and in mothers with general
infections is even less prominent. More research is needed to continue to understand the
relationship of STIs during pregnancy to ID in children.
2.5 Obesity & Pregnancy
Studies have long identified gestational obesity as a risk factor for multiple
adverse birth outcomes such as fetal distress, hypoxia, and preterm birth. This is due to
inflammation caused by increased adiposity(29). A 2013 cohort study found obese
mothers to be 2.01 (95% CI, 1.66-2.45) times as likely than mothers who were normal
weight to experience an extreme preterm birth, which is a leading cause of infant
mortality and neurocognitive defects(29). Furthermore, morbidly obese mothers were
found to have nearly a three-fold increase (95% CI, 2.28-3.92) in extreme pre-term birth
risk (29).
2.6 Obesity & Intellectual Disability
The relationship between obesity and infection is not well understood. There have
been several studies on the association between obesity and risk for autism spectrum
disorder in infants(16, 30). A 2016 meta-analysis found mothers who were obese during
pregnancy to be a pooled 1.47 times as likely to have a child with ASD (16). However,
less research has been done on maternal obesity and ID within the last decade, though the
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existing research does show evidence of an association. A 2013 study found the odds of
having a child with ID in women with morbid obesity were 1.52 (95% CI1.30 – 1.77))
times that of women of normal weight(17). Another study found that after adjusting for
confounders, obese mothers were 1.64 HR (1.09–2.45 CI) times as likely to have a baby
with ID than mothers who were normal weight (31).
2.7 Obesity & Infection
The relationship between obesity and infection is not well understood. Multiple
studies have shown that obese individuals have a greater risk of certain infections such as
nosocomial, skin infection, and UTIs (31-33). Additionally, the severity of certain
infections has been found to be heightened by obesity, and this results in increased
inflammation (18, 31). However, there is conflicting research regarding the role obesity
plays in other infections such as pneumonia and influenza (34). Regardless, because both
infection and obesity are pro-inflammatory conditions that have been found to increase
the risk of ID, it is reasonable to hypothesize that when they are both present in pregnant
women there is a multiplicative increase in the risk of ID.
2.8 Inflammation
Inflammation is a necessary physiological response to infection. It manifests itself
by fever, swelling, redness, and stiffness. It plays a complex role in pregnancy, as there is
expected inflammation in normal pregnancies, and maintaining a healthy level is
immensely important as it offers protection from infections (35). However, elevated
inflammation can cause multiple adverse effects during pregnancy such as fetal distress,
preterm birth, or fetal rejection. To mitigate this, during pregnancy there is a
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“immunological shift”; that is, hormones modulate inflammatory immune response, and
reduce natural killer cells, macrophages, and inflammatory cytokines while
simultaneously producing more anti-inflammatory cytokines (23). This reduces
inflammatory immune response to infection, and in turn, reduces the risk of fetal
rejection. However, in many cases such as with an infection or in obese women,
inflammation levels can increase, therefore endangering the fetus. Such circumstances
can result in adverse outcomes such as fetal distress and neurological disorders. A recent
study found that mothers with a C-reactive protein level that was at the highest quintile,
which suggests extensive inflammation, had a 43% higher risk of a child with autism than
mothers with CRP levels of the lowest quintile. (5). In another study, research found that,
independent of gestational age, elevated inflammation in the mother has been found to
increase the risk of brain injury (36). A preliminary Direct Acyclic Graph (DAG)
representing the relationship between gestational infection, obesity, and ID in children
can be found in Figure 2.1:
Future studies should assess the implications of the associations between
infection and ID, including possible mechanisms and effect modifiers. To understand the
etiology of ID, researchers must understand and acknowledge the complexities of the
causal pathway between preventable risk factors and ID. This paper aims to contribute to
this understanding by exploring the relationship between infection, obesity, and ID.
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Figure 2.1: Direct Acyclic Graph (DAG) of the Association Between Gestational Infections and Intellectual Disability

Chapter 3
Methods
3.1 Data
We conducted a retrospective cohort study using linked data for pregnant women
and their child who were born between the years of 2004 and 2010. Such records included:
South Carolina Medicaid records, South Carolina Department of Education (DOE) records,
birth certificates, and the South Carolina Department of Disabilities and Special Needs
(DDSN). This dataset consists of 124,047 linked maternal and singleton birth records. This
study was approved by the Institutional Review Board of the University of South Carolina
and is a follow-up study to research performed by Wang et al. which assessed possible
prevention of intellectual disability in children(4).
3.2 Data Inclusion & Exclusion Criteria
Data included children of singleton births whose mothers were enrolled in Medicaid
during pregnancy and their child remained insured by Medicaid until they were at least
three years old, or who were enrolled in public school and were present in the State
Department of Education (SDE) files. This study included children who were identified as
having an ID or not having an ID by the end of 2013 in either Medicaid, DOE, or DDSN
data sets. If a child was identified as having an ID through two or more of the databases,
they were included as having an ID in the study. Children diagnosed with known causes of
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ID such as an amino acid disorder, deformities of the brain, autosomal deletion, congenital
infections, genetic disorders, and fetal alcohol syndrome were excluded.
3.3 Exposures of Interest
Maternal infections were recorded in the Medicaid dataset using ICD-9 codes.
These infections included bronchitis, cytomegalovirus, coxsackie, gingivitis, influenza,
malaria, mononucleosis, pneumonia, pyelonephritis, rickettsia, rubella, skin infections,
tuberculosis, urinary tract infections, chlamydia, gonorrhea, GU infection, syphilis, and
trichomonas. Infections were then separated into “STI” and “general infections”.
Chlamydia, urinary tract infections, gonorrhea, GU infection, syphilis, and trichomonas,
and “other STD” were placed into the “STI” category, while bronchitis, cytomegalovirus,
coxsackie, gingivitis, influenza, malaria, mononucleosis, pneumonia, pyelonephritis,
rickettsia, rubella, skin infections, and tuberculosis were placed in the “General Infection”
category. An “Infection Category” variable was added in order to assess the differences in
association between Sexually Transmitted Infections and General Infections. Therefore,
mothers with neither STI nor general infection fell into Infection Category 1 (no infection),
mothers with general infection only were placed in infection category 2 (GI), mothers with
only a sexually transmitted infection fell into infection category 3 (STI), and finally,
women who experienced both a general infection and sexually transmitted infection during
pregnancy fell into infection category 4 (GI & STI).
In order to make inference on the interaction of BMI and infection category,
assessment of the continuous variable BMI was performed preliminarily. However, for
stratified analysis, the variable was then categorized. BMIs below 18.5 were categorized
as underweight, BMIs between 18.5 and 25.0 were categorized as normal weight, BMIs
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between 25.0 and 30.0 were categorized as overweight, BMIs above 30.0 were labeled as
obese.
3.4 Outcome of Interest
Intellectual disability in children was recorded after follow-up of at least 3 years. A
diagnosis within the Medicaid data set required an ICD-9 code of 317, 318, or 319. Within
the DOE data set, a diagnosis required either an “educable mentally handicapped” (EMH),
“trainable mentally handicapped” (TMH), or “Profoundly mentally handicapped” (PMH)
code. These diagnoses were grouped to make the ID variable dichotomous.
3.5 Potential Confounders
Each confounder has had prior research providing evidence of possible association
with both STIs and ID as well as Obesity and ID. Confounders that were considered when
building the model were small for gestational age (SGA), which was a combination of the
child’s sex, gestational age, and birthweight, in addition to maternal age, race, education,
and receipt of the Special Supplemental Nutrition Program for Women, Infants, and
Children (WIC) (37-45).
3.6 Statistical Analysis
A mediation analysis was then done for small gestational age, as literature provided
evidence to believe it mediated the relationship between Infection Category and ID. The
odds of having a child with ID for those with Infection, STI, or obesity were assessed using
multiple logistic regression models on SAS 9.4. Descriptive maternal and newborn
characteristics were compared between infants with and without ID, and a chi-square test
was used to determine statistical significance for unadjusted comparisons.
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BMI was first treated continuously in order to efficiently test for interaction. It was
noted that BMI proved to be a non-linear variable; therefore, a non-parametric regression
was performed to assess the relationship between the odds of ID and BMI. This regression
suggested that the association was meaningfully different for women with a BMI less than
19kg/m2, as compared to women with a larger BMI. To account for this, a linear spline was
fitted to the variable to allow the association between BMI and the odds of ID to change at
19 kg/m2. Once the spline was found significant, an interaction term between the
continuous BMI variable, now including the spline, was assessed. Once this term was
found significant, BMI was then categorized in order to stratify to produce interpretable
odds ratios. The final model assessed is as follows:
ID = INFCAT, BMI, Small Gestational Age, Mother’s Age, Mother’s Race, Alcohol
During Pregnancy, Tobacco During Pregnancy, Drug Use,
and Infection*BMI Interaction
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Chapter 4
Results
There was a total of 204,282 singleton births between the years of 2004 and 2010.
In this study, 42,787 children were excluded that had a known cause of ID, 17,203 were
lost to follow up, and 231 only had a single ID diagnosis out of the three linked datasets.
As a result, the final study sample included 124,047 mother and children pairs. A flowchart of all subject exclusions can be found in Figure 4.1, and descriptive data can be found
in Table 4.1.

Figure 4.1: Subject Summary
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Table 4.1: Study Descriptive Characteristics
Variable
ID (4,781)
Mother's Age
24.32
Mean Age
Mother's Education
2,031 (42.71%)
Less Than Hs Grad
2,724 (57.29%)
Hs Grad & Up
Mother's Race
2,235 (46.86%)
Black
67 (14.09%)
Other
1,863 (39.06%)
White
WIC
787 (16.73%)
No
3,916 (83.27%)
Yes
Mother's BMI
28.15
Mean BMI
405 (8.47%)
Underweight
1,616 (33.80%)
Normal Weight
1,168 (24.44%)
Overweight
1,591 (33.28%)
Obese
Mother ID
4,342 (90.84%)
No
438 (9.16%)
Yes
Baby Birthweight
371 (7.76%)
Low Birthweight
4,171 (87.26%)
Normal Birthweight
238 (4.98%)
Heavy Birthweight
Gestational Age
39 (0.82%)
<33 Weeks
363 (7.59%)
33-37 Weeks
4,378 (91.59%)
37 - 43 Weeks
Small for Gestational Age
3,945 (82.81%)
No
819 (17.19%)
Yes
Tobacco During
Pregnancy
3,712 (77.66%)
No
1,068 (22.34%)
Yes
Alcohol During Pregnancy
4,746 (99.29%)
No
34 (0.71%)
Yes
Drugs
4,523 (94.62%)
No
257 (5.38%)
Yes
Asthma
4,169 (87.22%)
No
16

No ID (119,266)

P – Value

23.32

<.0001
<.0001

43,873 (36.92%)
74,958 (63.08%)
<.0001
57,281 (48.05%)
14,397 (12.08%)
47,528 (39.87%)
<.0001
22,716 (19.37%)
94,582 (80.63%)
27.43
8,918 (7.48%)
45,330 (38.01%)
29,783 (24.98%)
35,224 (29.54%)

<.0001

<.0001
115,034 (96.46%)
4,220 (3.54%)
<.0001
7,079 (5.94%)
106,509 (89.31%)
5,666 (4.75%)
<.0001
328 (0.28%)
7,259 (6.09%)
111,667 (93.64%)
<.0001
102,197 (85.79%)
16,927 (14.21%)
<.0001
95,615 (80.18%)
23,639 (19.82%)
<.0001
118,893 (99.70%)
361 (0.30%)
<.0001
116,002 (97.27%)
3,252 (2.73%)
<.0001
108,034 (90.59%)

Yes
Cerebral Palsy
No
Yes
Epilepsy
No
Yes
Pregnancy Diabetes
No
Yes
Maternal Hypertension
No
Yes
Multiple Sclerosis
No
Yes
Rheumatoid Arthritis
No
Yes
Bronchitis
No
Yes
Coxsackie
No
Yes
Cytomegalovirus
No
Yes
Influenza
No
Yes
Gingivitis
No
Yes
Malaria
No
Yes
Mono
No
Yes
Pneumonia
No
Yes
Rickettsia
No
Yes

611 (12.78%)

11,220 (9.41%)

4,772 (99.81%)
9 (0.19%)

119,142 (99.91%)
112 (0.09%)

60 (1.26%)
4,720 (98.74%)

2,863 (2.40%)
116,391 (97.60%)

0.0445

<.0001

0.0027
4,471 (93.54%)
309 (6.46%)

112,750 (94.55%)
6,504 (5.45%)

3,824 (80.00%)
956 (20.00%)

99,704 (83.61%)
19,550 (16.39%)

<.0001

0.0406
4,772 (99.83)
8 (0.17%)

119,160 (99.92%)
94 (0.08%)
0.1112

4,763 (99.64%)
17 (0.36%)

118,968 (99.76%)
286 (0.24%)

4,649 (97.26%)
131 (2.74%)

116,791 (97.93%)
2463 (2.07%)

0.0014

0.9396
4,780 (100.00%)
0 (0.00%)

119,247 (99.99%)
7 (0.01%)
0.9278

4,780 (100.00%)
0 (0.00%)

119,244 (99.99%)
10 (0.01%)

4,733 (99.02%)
47 (0.98%)

118,351 (99.24%)
903 (0.76%)

0.0791

0.0142
4,766 (99.71%)
14 (0.29%)

119,077 (99.85%)
177 (0.15%)

4,780 (100.00%)
0 (0.00%)

119,252 (100.00%)
2 (0.00%)

4,778 (99.96%)
2 (0.04%)

119,236 (99.98%)
18 (0.02%)

0.934

0.1679

0.1443
4,762 (99.62%)
18 (0.38%)

118,938 (99.74%)
316 (0.26%)

4,758 (99.54%)
22 (0.46%)

118,931 (99.73%)
323 (0.27%)

0.016
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Rubella
No
Yes
Skin Infection
No
Yes
Tuberculosis
No
Yes
Infection
No
Yes
Chlamydia
No
Yes
Cystitis
No
Yes
Gonorrhea
No
Yes
G.U. Infection
No
Yes
Other STD
No
Yes
Pyelonephritis
No
Yes
Syphilis
No
Yes
Trichomonas
No
Yes
STI
No
Yes
Infection Category
No Infection
General Infection
Sexually Transmitted
Infection
STI & GI

0.7902
4,779 (99.98%)
1 (0.02%)

119,235 (99.98%)
19 (0.02%)

4,648 (97.24%)
132 (2.76%)

116,511 (97.70%)
2,743 (2.30%)

4,780 (100.00%)
0 (0.00%)

119,240 (99.99%)
14 (0.01%)

0.0379

0.9146

<.0001
4,452 (93.14%)
328 (6.86%)

112,871 (94.65%)
6,383 (5.35%)

4,656 (97.38%)
125 (2.62%)

116,362 (97.57%)
2,892 (2.43%)

3,680 (76.99%)
1,100 (23.01%)

94,511 (79.25%)
24,743 (20.75%)

0.4039

0.0002

0.4008
4,716 (98.66%)
64 (1.34%)

117,819 (98.80%)
1,435 (1.20%)

3,758 (78.62%)
1,022 (21.38%)

97,324 (81.61%)
21,930 (18.39%)

4,775 (99.90%)
5 (0.10%)

118,946 (99.74%)
308 (.03)

<.0001

0.0448

0.4771
4,697 (98.26%)
83 (1.74%)

117,334 (98.39%)
1,920 (1.61%)

4,774 (99.87%)
6 (0.13%)

119,053 (99.83%)
201 (0.17%)

0.4799

0.0121
4,627 (96.80%)
153 (3.20%)

116,144 (97.39%)
3,110 (2.61%)
<.0001

3,163 (66.18%)
1,617 (33.82%)

82,433 (69.13%)
36,821 (30.87%)

2,989 (62.53%)
174 (3.64%)

78,824 (66.10%)
3,609 (3.03%)

1,463 (30.60%)

34,047 (28.55%)

154 (3.22%)

2,774 (2.33%)

<.0001
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Means are reported for continuous variables, and frequencies are reported for
categorical variables.
P-value is calculated by using chi-squared test.
Because birthweight and gestational age are widely recognized mediators between
certain gestational risk factors and ID, a mediation analysis was performed assessing the
variables’ influence on the relationship between infection category and ID. After mediation
assessment was complete, it was concluded that both gestational age and small for
gestational age did not significantly mediate the relationship between Infection Category
and ID. Results of this analysis can be found in Table 4.2, and the final DAG after analysis
can be seen in figure 4.2.
Table 4.2: Mediation Analysis for Small Gestational Age
Variable
GI
STI
GI & STI
1.25
1.17
1.44
OR Without SGA
1.25
1.17
1.44
OR With SGA
0.00% 0.00%
0.00%
Percent Difference
1.25
1.17
1.44
OR Without Gest. Age
1.24
1.16
1.43
OR With Gest. Age
0.72% 0.77%
0.49%
Percent Difference

When selecting a knot for the linear spline regression of the continuous BMI
variable, a F-test assessment found the knot to be significant (P-value 0.026). Therefore,
the spline was a good fit to the variable, and could be used in the model with an interaction
term with Infection Category. An F-test of both the interaction term with BMI and the knot
were found significant (P-values .023 and .026, respectively); there is evidence that BMI
and infection category do interact. Because of this, in order to assess the effect BMI has on
the relationship between gestational infection and ID in children, the analysis was stratified
by BMI category.
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The results of this analysis can be seen in Table 4.3. Within each stratum, the odds
ratios for each infection category change both in magnitude and in significance. There was
a 5.17% change in the odds ratios for STIs between the overweight and obese categories.
The most substantial change was found between the underweight and obese categories
within the GI & STI infection category (87.76%). When comparing individual infection
categories, there were no significant differences between STI and GI categories, there was
a substantial increase of odds within GI & STI category when comparing to both GI & STI
alone. No other differences were found.
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Table 4.3: Odds Ratios from Logistic Regression Models of Intellectual Disability for Infection Category Stratified by BMI
Category**
Normal Weight (n = 46,950) Underweight (n = 9,323) Overweight (n = 30,956)
Obese (n= 36,818)
Variable
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
No
Infection
REF
REF
REF
REF
REF
REF
REF
REF
1.26
0.96 - 1.66
0.73
0.34 - 1.58
1.22
0.86 - 1.72
GI
1.34
1.05 - 1.72
1.12
1.00 - 1.25
1.16
0.92 - 1.47
STI
1.16
1.01 - 1.32
1.22
1.09 - 1.37
1.18
0.85 - 1.65
1.32
0.92 - 1.90
GI & STI
2.76
1.68 - 4.53
1.47
1.13 - 1.91
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Comparing to General Infection
Normal Weight
Variable
OR
95% CI
GI
REF
REF
0.89
0.67 - 1.18
STI
0.92
0.61 - 1.41
GI & STI

Underweight
OR
95% CI
REF
REF
1.56
0.72 - 3.39
3.76
1.54 - 9.17

OR
REF
0.95
1.08

Overweight
95% CI
REF
0.67 - 1.35
0.66 - 1.76

OR
REF
0.90
1.09

Obese
95% CI
REF
0.70 - 1.16
0.77 - 1.534

Comparing to Sexually Transmitted Infection
Normal Weight
Underweight
Overweight
Obese
Variable
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
STI
REF
REF
REF
REF
REF
REF
REF
REF
1.13
0.85 - 1.50
0.64
0.30 - 1.40
1.05
0.74 - 1.50
1.11
0.86 - 1.43
GI
1.04
0.742 - 1.46
1.14
0.78 - 1.65
1.21
0.92 - 1.575
GI & STI
2.41
1.44 - 4.03
**Controlling for mother's age, mother's race, alcohol use, tobacco use, drug use, small gestational age

Chapter 5
Discussion
Multiple analyses were run in this study assessing potential interaction and
association between maternal infection and obesity and ID in children. Mediation analysis
found that SGA was not a mediator in the relationship between maternal infection and ID.
After adjusting for multiple confounders, the results found in this study provided evidence
that supports the presence of effect modification by BMI; however, this was manifested
within underweight mothers rather than obese mothers. Underweight mothers were nearly
3 times as likely to have an intellectually disabled child if they had both a general infection
and sexually transmitted infection. In comparison, obese mothers were 1.47 times as likely
to birth a child with ID if they had such infections. This nearly 88% difference in stratumspecific odds ratios corroborated the presence of effect modification by BMI. Furthermore,
this research provided evidence that partially supported the hypothesis that there was a
significant difference between infection categories in their association to ID in children. In
underweight mothers, when compared to general and sexually transmitted infections alone,
the odds of having a child with ID was greatly increased in mothers that experienced both
a GI & STI during pregnancy. However, in every BMI stratum, no significant difference
was found between STI and GI categories.
5.1 Stratum Specific Analyses
Within the underweight category, BMI greatly modifies the relationship between
infection and ID. Underweight mothers were nearly 3 times as likely to birth a child with
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ID if they had both a general infection and sexually transmitted infection. In comparison,
obese mothers were 1.47 times as likely to birth a child with ID if they had such infections.
5.2 Comparisons of Infection Categories
Because of the stratified analysis, comparisons of the associations between each
infection category and ID could be made. It was hypothesized that mothers with a sexually
transmitted infection would have significantly greater odds of having a child with ID as
compared to mothers with a general infection. No significant differences in odds of ID
were observed in mothers with an STI as compared to mothers with a GI across any of the
BMI strata. difference was seen in any BMI category.
Additionally, it was also hypothesized that the odds of having a child with ID in
mothers that experience both a GI and an STI during pregnancy would be significantly
greater as compared to both general infections and sexually transmitted infections alone.
Stratified analysis shows that within underweight women, the presence of both a GI & STI
during pregnancy greatly increased the odds of ID in the child when compared to both
general infections and sexually transmitted infections alone (OR 3.76 & 2.41, respectively).
However, within normal weight, overweight, and obese mothers, no significant differences
were found. Additionally, there was no significant difference of increased odds across the
BMI strata for STI and general infections.
5.3 The Mechanism: Inflammation
The effect of BMI on the relationship between gestational infection and ID in
children is likely due to excess inflammation. A crucial part of the human immunological
system, inflammation plays a complex role in pregnancies. Too little inflammation makes
a mother, and thus, the baby, more susceptible for infection. However, too much
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inflammation can cause severe adverse health outcomes for both the mother and the fetus
such as fetal distress and rejection, hypoxia, and neurological outcomes such as ID.
Inflammation and BMI have a U-shaped association(47). Underweight individuals
experience greater levels of inflammation than those who are normal or overweight.
Additionally, underweight mothers are more susceptible to infection, also a proinflammatory condition. Therefore, the presence of an infection during the pregnancy of
an underweight mother could potentially see inflammation be exponentially increased.
This could explain why underweight mothers saw the only difference of odds ratios for
mothers who experienced both a GI & STI during their pregnancy. Similarly, obese
mothers experience excess inflammation, and the presence of an infection within an obese
mother could also cause increased inflammation. This corroborates the significant changes
in the odds ratios of infections for underweight and overweight mothers represented in the
stratum-specific analyses.
5.4 Strengths & Limitations
The sample size is very large (n = 124,047), and consists of SC mothers covered by
Medicaid, which covers pregnant women up to 185% of poverty. Therefore, the study is
homogenous, and is representative of the general population of women in SC who are lowincome. However, there were several limitations within the study. There was no
information on medication within this dataset; and medication taken could
disproportionally impact the severity or the impact of the infection in the sample, therefore
biasing the result. Additionally, although the presence of infection during pregnancy is
noted within this dataset, there is no information on the timeline of infection. Future studies
that include this temporal information would allow the researcher to assess the importance
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of time of infection in its association to ID in children. Finally, this dataset lists ID as a
dichotomous outcome; however, ID is, in reality, a continuous outcome with varying
severity. It is possible that certain infections could be differentially associated with mild,
moderate, or severe ID. Therefore, future studies should use either the numeric values for
the intelligence score, or a categorical variable representing the severity of the ID, rather
than the dichotomous outcome used in this study.
5.5 Conclusion
These findings within this retrospective cohort study are in line with previous
related literature. This study contributes to understanding the association between maternal
infection and ID in children, as well as the effect BMI holds on the relationship. However,
further research that thoroughly assesses biological mechanisms, impact of medications,
and timeline for infection, continuous measure of maternal BMI, and category of ID,
should be done. To further understand the etiology of ID, researchers must understand and
acknowledge the complexities of the mechanisms and relationships between infection,
obesity, and intellectual disability.
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